AKBA EPS Estimates
Akebia Therapeutics, Inc.
$0.70
-$0.07(-8.83%)
39
Overall
40
Value
40
Tech
39
Quality
Market Cap
$194.53M
Volume
13.96M
52W Range
$0.80 - $3.20
Target Price
$3.80
AKBA EPS estimates: the consensus estimate for Akebia Therapeutics, Inc.'s current fiscal year is -$0.14 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
AKBA EPS Estimates
- EPS estimate, current quarter
- $-0.03
- EPS estimate, next quarter
- $-0.04
- EPS estimate, current year
- $-0.14
- EPS estimate, next year
- $-0.27
- EPS growth, 3-year
- +66.03%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.02 |
| 2024 | $-0.33 |
| 2023 | $-0.28 |
| 2022 | $-0.51 |
| 2021 | $-1.70 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AKBA | $0.70 | -8.8% | 13.96M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Akebia Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW